Targeting epigenetics in cancer: therapeutic potential of flavonoids

References

• Afrin, S., F. Giampieri, M. Gasparrini, T. Y. Forbes-Hernández, D. Cianciosi, P. Reboredo-Rodriguez, J. Zhang, P. P. Manna, M. Daglia, A. G. Atanasov, et al. 2020. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances 38:107322. doi: 10.1016/j.biotechadv.2018.11.011.
   PubMed Web of Science ®Google Scholar
• Ahmad, A., T. Ali, H. Y. Park, H. Badshah, S. U. Rehman, and M. O. Kim. 2017. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Molecular Neurobiology 54 (3):2269–85. doi: 10.1007/s12035-016-9795-4.
   PubMed Web of Science ®Google Scholar
• Ahuja, N., A. R. Sharma, and S. B. Baylin. 2016. Epigenetic therapeutics: A new weapon in the war against cancer. Annual Review of Medicine 67 (1):73–89. doi: 10.1146/annurev-med-111314-035900.
   PubMedGoogle Scholar
• Allred, C. D., Y. H. Ju, K. F. Allred, J. Chang, and W. G. Helferich. 2001. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22 (10):1667–73. doi: 10.1093/carcin/22.10.1667.
   PubMed Web of Science ®Google Scholar
• Anestopoulos, I., A. Sfakianos, R. Franco, K. Chlichlia, M. Panayiotidis, D. Kroll, and A. Pappa. 2016. A novel role of silibinin as a putative epigenetic modulator in human prostate carcinoma. Molecules 22 (1):62. doi: 10.3390/molecules22010062.
   Web of Science ®Google Scholar
• Appari, M., K. R. Babu, A. Kaczorowski, W. Gros, and I. Her. 2014. Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. International Journal of Oncology 45 (4):1391–400. doi: 10.3892/ijo.2014.2539.
   PubMed Web of Science ®Google Scholar
• Attoub, S., A. H. Hassan, B. Vanhoecke, R. Iratni, T. Takahashi, A.-M. Gaben, M. Bracke, S. Awad, A. John, H. A. Kamalboor, et al. 2011. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. European Journal of Pharmacology 651 (1-3):18–25. doi: 10.1016/j.ejphar.2010.10.063.
   PubMed Web of Science ®Google Scholar
• Ayissi, V. B. O., A. Ebrahimi, and H. Schluesenner. 2014. Epigenetic effects of natural polyphenols: A focus on SIRT1-mediated mechanisms. Molecular Nutrition & Food Research 58 (1):22–32. doi: 10.1002/mnfr.201300195.
   PubMed Web of Science ®Google Scholar
• Babiarz, J. E., J. G. Ruby, Y. Wang, D. P. Bartel, and R. Blelloch. 2008. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes & Development 22 (20):2773–85. doi: 10.1101/gad.1705308.
   PubMed Web of Science ®Google Scholar
• Balasubramanian, S., G. Adhikary, and R. L. Eckert. 2010. The Bmi-1 polycomb protein antagonizes the (−)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 31 (3):496–503. doi: 10.1093/carcin/bgp314.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and T. Kouzarides. 2011. Regulation of chromatin by histone modifications. Cell Research 21 (3):381–95. doi: 10.1038/cr.2011.22.
   PubMed Web of Science ®Google Scholar
• Barreca, D., E. Bellocco, G. D'Onofrio, S. Fazel Nabavi, M. Daglia, L. Rastrelli, and S. Mohammad Nabavi. 2016. Neuroprotective effects of quercetin: From chemistry to medicine. CNS & Neurological Disorders - Drug Targets 15 (8):964–75. doi: 10.2174/1871527315666160813175406.
   PubMed Web of Science ®Google Scholar
• Baruah, M. M., A. P. Khandwekar, and N. Sharma. 2016. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases. Tumor Biology 37 (10):14025–34. doi: 10.1007/s13277-016-5277-6.
   PubMedGoogle Scholar
• Bast, A., G. R. Haenen, A. M. Bruynzeel, and W. J. Van der Vijgh. 2007. Protection by flavonoids against anthracycline cardiotoxicity: From chemistry to clinical trials. Cardiovascular Toxicology 7 (2):154–9. doi: 10.1007/s12012-007-0018-0.
   PubMed Web of Science ®Google Scholar
• Berger, A., S. Venturelli, M. Kallnischkies, A. Böcker, C. Busch, T. Weiland, S. Noor, C. Leischner, T. S. Weiss, U. M. Lauer, et al. 2013. Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. The Journal of Nutritional Biochemistry 24 (6):977–85. doi: 10.1016/j.jnutbio.2012.07.001.
   PubMed Web of Science ®Google Scholar
• Berger, N. A. 2016. Epigenetics, energy balance, and cancer. Basel, Switzerland: Springer.
   Google Scholar
• Berghe, W. V. 2012. Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes. Pharmacological Research 65:565–76.
   PubMed Web of Science ®Google Scholar
• Berletch, J. B., C. Liu, W. K. Love, L. G. Andrews, S. K. Katiyar, and T. O. Tollefsbol. 2008. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. Journal of Cellular Biochemistry 103 (2):509–19. doi: 10.1002/jcb.21417.
   PubMed Web of Science ®Google Scholar
• Bernstein, E., A. A. Caudy, S. M. Hammond, and G. J. Hannon. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (6818):363–6. doi: 10.1038/35053110.
   PubMed Web of Science ®Google Scholar
• Bettuzzi, S., M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Research 66 (2):1234–40. doi: 10.1158/0008-5472.CAN-05-1145.
   PubMed Web of Science ®Google Scholar
• Bishayee, K., A. R. Khuda-Bukhsh, and S. O. Huh. 2015. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Molecules and Cells 38 (6):518–27. doi: 10.14348/molcells.2015.2339.
   PubMed Web of Science ®Google Scholar
• Blair, C. K., A. S. Kelly, J. Steinberger, L. E. Eberly, C. Napurski, K. Robien, J. P. Neglia, D. A. Mulrooney, and J. A. Ross. 2014. Feasibility and preliminary efficacy of the effects of flavanoid-rich purple grape juice on the vascular health of childhood cancer survivors: A randomized, controlled crossover trial. Pediatric Blood & Cancer 61 (12):2290–6. doi: 10.1002/pbc.25202.
   PubMed Web of Science ®Google Scholar
• Bogdanović, O., and G. J. C. Veenstra. 2009. DNA methylation and methyl-CpG binding proteins: Developmental requirements and function. Chromosoma 118 (5):549–65. doi: 10.1007/s00412-009-0221-9.
   PubMed Web of Science ®Google Scholar
• Bohnsack, M. T., K. Czaplinski, and D. Görlich. 2004. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10 (2):185–91. doi: 10.1261/rna.5167604.
   PubMed Web of Science ®Google Scholar
• Bosch-Barrera, J., and J. A. Menendez. 2015. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treatment Reviews 41 (6):540–6. doi: 10.1016/j.ctrv.2015.04.008.
   PubMed Web of Science ®Google Scholar
• Bots, M., and R. W. Johnstone. 2009. Rational combinations using HDAC inhibitors. Clinical Cancer Research 15 (12):3970–7. doi: 10.1158/1078-0432.CCR-08-2786.
   PubMed Web of Science ®Google Scholar
• Büchler, P., A. Gazdhar, M. Schubert, N. Giese, H. A. Reber, O. J. Hines, T. Giese, G. O. Ceyhan, M. Müller, M. W. Büchler, et al. 2005. The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Annals of Surgery 242:791.
   PubMed Web of Science ®Google Scholar
• Busch, C., M. Burkard, C. Leischner, U. M. Lauer, J. Frank, and S. Venturelli. 2015. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clinical Epigenetics 7 (1):64. doi: 10.1186/s13148-015-0095-z.
   PubMedGoogle Scholar
• Bussemakers, M. J., A. van Bokhoven, G. W. Verhaegh, F. P. Smit, H. F. Karthaus, J. A. Schalken, F. M. Debruyne, N. Ru, and W. B. Isaacs. 1999. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Research 59 (23):5975–9.
   PubMed Web of Science ®Google Scholar
• Byrne, M. M., R. T. Murphy, and A. W. Ryan. 2014. Epigenetic modulation in the treatment of atherosclerotic disease. Frontiers in Genetics 5:364. doi: 10.3389/fgene.2014.00364.
   PubMed Web of Science ®Google Scholar
• Cassidy, A., T. Huang, M. Rice, E. Rimm, and S. Tworoger. 2014. Intake of dietary flavonoids and risk of epithelial ovarian cancer. The American Journal of Clinical Nutrition 100 (5):1344–51. doi: 10.3945/ajcn.114.088708.
   PubMed Web of Science ®Google Scholar
• Che, J., B. Liang, Y. Zhang, Y. Wang, J. Tang, and G. Shi. 2017. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in human endothelial cells. Cardiovascular Pathology 31:57–62. doi: 10.1016/j.carpath.2017.08.001.
   PubMed Web of Science ®Google Scholar
• Chen, H.-Q., J. Zhao, Y. Li, L.-X. He, Y.-J. Huang, W.-Q. Shu, J. Cao, W.-B. Liu, and J.-Y. Liu. 2018. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells. Toxicology Letters 289:42–53. doi: 10.1016/j.toxlet.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Choi, J. H., S. E. Park, S. J. Kim, and S. Kim. 2015. Kaempferol inhibits thrombosis and platelet activation. Biochimie 115:177–86. doi: 10.1016/j.biochi.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Cohen, I., E. Poreba, K. Kamieniarz, and R. Schneider. 2011. Histone modifiers in cancer: Friends or foes? Genes & Cancer 2 (6):631–47. doi: 10.1177/1947601911417176.
   PubMedGoogle Scholar
• Copeland, R. A., M. E. Solomon, and V. M. Richon. 2009. Protein methyltransferases as a target class for drug discovery. Nature Reviews Drug Discovery 8 (9):724–32. doi: 10.1038/nrd2974.
   PubMed Web of Science ®Google Scholar
• Cui, L., X. Liu, Y. Tian, C. Xie, Q. Li, H. Cui, and C. Sun. 2016. Flavonoids, flavonoid subclasses, and esophageal cancer risk: A meta-analysis of epidemiologic studies. Nutrients 8 (6):350–65. doi: 10.3390/nu8060350.
   Web of Science ®Google Scholar
• Curti, V., A. D. Lorenzo, D. Rossi, E. Martino, E. Capelli, S. Collina, and M. Daglia. 2017. Enantioselective modulatory effects of naringenin enantiomers on the expression levels of miR-17-3p involved in endogenous antioxidant defenses. Nutrients 9 (3):215. doi: 10.3390/nu9030215.
   Web of Science ®Google Scholar
• Dagdemir, A., J. Durif, M. Ngollo, Y. J. Bignon, and D. Bernard-Gallon. 2013. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics 5 (1):51–63. doi: 10.2217/epi.12.74.
   PubMed Web of Science ®Google Scholar
• Damsky, W. E., D. P. Curley, M. Santhanakrishnan, L. E. Rosenbaum, J. T. Platt, B. E. Gould Rothberg, M. M. Taketo, D. Dankort, D. L. Rimm, M. McMahon, et al. 2011. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20 (6):741–54. doi: 10.1016/j.ccr.2011.10.030.
   PubMed Web of Science ®Google Scholar
• Dasgupta, A., and K. Klein. 2014. Chapter 12: Fruits, vegetables, and nuts: Good sources of antioxidants. In Antioxidants in food, vitamins and supplements, 209–35. San Diego, CA: Elsevier.
   Google Scholar
• Davis-Dusenbery, B. N., and A. Hata. 2010. Mechanisms of control of microRNA biogenesis. The Journal of Biochemistry 148:381–92.
   PubMed Web of Science ®Google Scholar
• de Pascual-Teresa, S., and M. T. Sanchez-Ballesta. 2008. Anthocyanins: From plant to health. Phytochemistry Reviews 7 (2):281–99. doi: 10.1007/s11101-007-9074-0.
   Google Scholar
• Derrien, T., R. Guigó, and R. Johnson. 2012. The long non-coding RNAs: A new (p) layer in the “dark matter”. Frontiers in Genetics 2:107. doi: 10.3389/fgene.2011.00107.
   PubMedGoogle Scholar
• Devi, K. P., D. S. Malar, S. F. Nabavi, A. Sureda, J. Xiao, S. M. Nabavi, and M. Daglia. 2015. Kaempferol and inflammation: From chemistry to medicine. Pharmacological Research 99:1–10. doi: 10.1016/j.phrs.2015.05.002.
   PubMed Web of Science ®Google Scholar
• Dhillon, N., B. B. Aggarwal, R. A. Newman, R. A. Wolff, A. B. Kunnumakkara, J. L. Abbruzzese, C. S. Ng, V. Badmaev, and R. Kurzrock. 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14 (14):4491–99. doi: 10.1158/1078-0432.CCR-08-0024.
   PubMed Web of Science ®Google Scholar
• Donado, F., U. Sandoval, and J. Carrillo. 2011. Viscosity enhancement in dilute magnetorheological fluids through magnetic perturbations. Revista Mexicana de Física 57:426–34.
   Web of Science ®Google Scholar
• Dong, Z., and Y. J. Surh. 2008. Dietary modulation of cell signaling pathways. Boca Raton, FL: CRC Press.
   Google Scholar
• Duthie, G., and K. Brown. 1994. Reducing the risk of cardiovascular disease, functional foods: Designer foods, pharma foods, nutraceuticals, 19. Upper Saddle River, NJ: Chapman & Hall.
   Google Scholar
• Ehrlich, M., and M. Lacey. 2013. DNA hypomethylation and hemimethylation in cancer. In Epigenetic alterations in oncogenesis, ed. A. Karpf, 31–56. New York, NY: Springer.
   Google Scholar
• ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57.
   PubMed Web of Science ®Google Scholar
• Fang, M. Z., D. Chen, Y. Sun, Z. Jin, J. K. Christman, and C. S. Yang. 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARβ, and MGMT genes by genistein and other isoflavones from soy. Clinical Cancer Research 11 (19):7033–41. doi: 10.1158/1078-0432.CCR-05-0406.
   PubMed Web of Science ®Google Scholar
• Fang, M., D. Chen, and C. S. Yang. 2007. Dietary polyphenols may affect DNA methylation. The Journal of Nutrition 137 (1):223S–8S. doi: 10.1093/jn/137.1.223S.
   PubMed Web of Science ®Google Scholar
• Ferry, D. R., A. Smith, J. Malkhandi, D. W. Fyfe, P. G. deTakats, D. Anderson, J. Baker, and D. J. Kerr. 1996. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2 (4):659–68.
   PubMed Web of Science ®Google Scholar
• Friedman, R. C., K. K. H. Farh, C. B. Burge, and D. P. Bartel. 2008. Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 19 (1):92–105. doi: 10.1101/gr.082701.108.
   PubMed Web of Science ®Google Scholar
• Gao, P., and G. H. Wei. 2017. Genomic insight into the role of lncRNAs in cancer susceptibility. International Journal of Molecular Sciences 18:1239.
   PubMed Web of Science ®Google Scholar
• Gao, Y. T., J. K. McLaughlin, W. J. Blot, B. T. Ji, Q. Dai, and J. F. Fraumeni. 1994. Reduced risk of esophageal cancer associated with green tea consumption. JNCI: Journal of the National Cancer Institute 86 (11):855–58. doi: 10.1093/jnci/86.11.855.
   PubMed Web of Science ®Google Scholar
• Gates, M., S. Tworoger, J. Hecht, I. De Vivo, B. Rosner, and S. Hankinson. 2007. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. International Journal of Cancer 121 (10):2225–32. doi: 10.1002/ijc.22790.
   PubMed Web of Science ®Google Scholar
• Gilbert, E., and D. Liu. 2010. Flavonoids influence epigenetic-modifying enzyme activity: Structure-function relationships and the therapeutic potential for cancer. Current Medicinal Chemistry 17 (17):1756–68. doi: 10.2174/092986710791111161.
   PubMed Web of Science ®Google Scholar
• Goldberg, I. 1994. Functional foods: Designer foods, pharmafoods, nutraceuticals. New York, NY: Springer.
   Google Scholar
• Goldberg, R., B. Motzkin, R. Marion, P. J. Scambler, and R. J. Shprintzen. 1993. Velo-cardio-facial syndrome: A review of 120 patients. American Journal of Medical Genetics 45 (3):313–9. doi: 10.1002/ajmg.1320450307.
   PubMed Web of Science ®Google Scholar
• Grishok, A., A. E. Pasquinelli, D. Conte, N. Li, S. Parrish, I. Ha, D. L. Baillie, A. Fire, G. Ruvkun, C. C. Mello, et al. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106 (1):23–34. doi: 10.1016/S0092-8674(01)00431-7.
   PubMed Web of Science ®Google Scholar
• Grosso, C., P. Valentão, C. Andrade, and P. B. Andrade. 2015. HPLC–DAD analysis and in vitro enzyme inhibition: An integrated approach to predict herbal binary mixture behaviour employing median effect equation. Microchemical Journal 119:176–82. doi: 10.1016/j.microc.2014.12.006.
   Web of Science ®Google Scholar
• Grosso, G., J. Godos, R. Lamuela-Raventos, S. Ray, A. Micek, A. Pajak, S. Sciacca, N. D'Orazio, D. Del Rio, F. Galvano, et al. 2017. A comprehensive meta‐analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Molecular Nutrition & Food Research 61 (4):1600930. doi: 10.1002/mnfr.201600930.
   Web of Science ®Google Scholar
• Guglas, K., M. Bogaczyńska, T. Kolenda, M. Ryś, A. Teresiak, R. Bliźniak, I. Łasińska, J. Mackiewicz, and K. Lamperska. 2017. lncRNA in HNSCC: Challenges and potential. Współczesna Onkologia 21 (4):259–66. doi: 10.5114/wo.2017.72382.
   Google Scholar
• Gupta, R. A., N. Shah, K. C. Wang, J. Kim, H. M. Horlings, D. J. Wong, M.-C. Tsai, T. Hung, P. Argani, J. L. Rinn, et al. 2010. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464 (7291):1071–6. doi: 10.1038/nature08975.
   PubMed Web of Science ®Google Scholar
• Hammond, S. M., S. Boettcher, A. A. Caudy, R. Kobayashi, and G. J. Hannon. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293 (5532):1146–50. doi: 10.1126/science.1064023.
   PubMed Web of Science ®Google Scholar
• Han, X. H., S. S. Hong, J. S. Hwang, M. K. Lee, B. Y. Hwang, and J. S. Ro. 2007. Monoamine oxidase inhibitory components from Cayratia japonica. Archives of Pharmacal Research 30 (1):13–7. doi: 10.1007/BF02977772.
   PubMed Web of Science ®Google Scholar
• Haque, I., A. Subramanian, C. Huang, A. Godwin, P. Van Veldhuizen, S. Banerjee, and S. Banerjee. 2017. The role of compounds derived from natural supplement as anticancer aagents in renal cell carcinoma: A review. International Journal of Molecular Sciences 19 (1):107. doi: 10.3390/ijms19010107.
   Web of Science ®Google Scholar
• Hardy, T. M., and T. O. Tollefsbol. 2011. Epigenetic diet: Impact on the epigenome and cancer. Epigenomics 3 (4):503–18. doi: 10.2217/epi.11.71.
   PubMed Web of Science ®Google Scholar
• Hasanpourghadi, M., A. K. Pandurangan, and M. R. Mustafa. 2018. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer. Pharmacological Research 128:376–88. doi: 10.1016/j.phrs.2017.09.009.
   PubMed Web of Science ®Google Scholar
• Hatcher, H. C., F. M. Torti, and S. V. Torti. 2012. Curcumin, oxidative stress, and cancer therapy. In Oxidative stress in cancer biology and therapy, eds. D. R. Spitz, K. J. Dornfeld, K. Krishnan, and D. Gius, 233–56. Totowa, NJ: Humana Press.
   Google Scholar
• Hertog, M. G., P. C. Hollman, and M. B. Katan. 1992. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry 40 (12):2379–83. doi: 10.1021/jf00024a011.
   Web of Science ®Google Scholar
• Hess, J. L. 2004. MLL: A histone methyltransferase disrupted in leukemia. Trends in Molecular Medicine 10 (10):500–7. doi: 10.1016/j.molmed.2004.08.005.
   PubMed Web of Science ®Google Scholar
• Hong, K.-S., J.-I. Park, M.-J. Kim, H.-B. Kim, J.-W. Lee, T. T. Dao, W. K. Oh, C.-D. Kang, and S.-H. Kim. 2012. Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β-catenin and hypoxic preconditioning effect of polyphenols. Toxicology and Applied Pharmacology 259 (2):210–8. doi: 10.1016/j.taap.2011.12.025.
   PubMed Web of Science ®Google Scholar
• Howells, L. M., D. P. Berry, P. J. Elliott, E. W. Jacobson, E. Hoffmann, B. Hegarty, K. Brown, W. P. Steward, and A. J. Gescher. 2011. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—Safety, pharmacokinetics, and pharmacodynamics. Cancer Prevention Research 4 (9):1419–25. doi: 10.1158/1940-6207.CAPR-11-0148.
   PubMed Web of Science ®Google Scholar
• Hsieh, C. Y. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 21 (2895):e2900.
   Google Scholar
• Hua, X., L. Yu, R. You, Y. Yang, J. Liao, D. Chen, and L. Yu. 2016. Association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk: A meta-analysis. PLoS One 11 (3):e0151134. doi: 10.1371/journal.pone.0151134.
   PubMed Web of Science ®Google Scholar
• Hui, C., X. Qi, Z. Qianyong, P. Xiaoli, Z. Jundong, and M. Mantian. 2013. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PloS One 8 (1):e54318. doi: 10.1371/journal.pone.0054318.
   PubMed Web of Science ®Google Scholar
• Huntzinger, E., and E. Izaurralde. 2011. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nature Reviews Genetics 12 (2):99–110. doi: 10.1038/nrg2936.
   PubMed Web of Science ®Google Scholar
• Hutvágner, G., J. McLachlan, A. E. Pasquinelli, É. Bálint, T. Tuschl, and P. D. Zamore. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (New York, N.Y.) 293 (5531):834–8. doi: 10.1126/science.1062961.
   PubMed Web of Science ®Google Scholar
• Im, H. I., and P. J. Kenny. 2012. MicroRNAs in neuronal function and dysfunction. Trends in Neurosciences 35 (5):325–34. doi: 10.1016/j.tins.2012.01.004.
   PubMed Web of Science ®Google Scholar
• Iwashina, T. 2015. Contribution to flower colors of flavonoids including anthocyanins: A review. Natural Product Communications 10 (3):1934578X1501000–44. doi: 10.1177/1934578X1501000335.
   Web of Science ®Google Scholar
• Jafarpour-Sadegh, F., V. Montazeri, A. Adili, A. Esfehani, M. R. Rashidi, and S. Pirouzpanah. 2017. Consumption of fresh yellow onion ameliorates hyperglycemia and insulin resistance in breast cancer patients during doxorubicin-based chemotherapy: A randomized controlled clinical trial. Integrative Cancer Therapies 16 (3):276–89. doi: 10.1177/1534735416656915.
   PubMed Web of Science ®Google Scholar
• Jatoi, A., N. Ellison, P. A. Burch, J. A Sloan, S. R. Dakhil, P. Novotny, W. Tan, T. R. Fitch, K. M. Rowland, C. Y. Young, et al. 2003. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97 (6):1442–46. doi: 10.1002/cncr.11200.
   PubMed Web of Science ®Google Scholar
• Ji, P., S. Diederichs, W. Wang, S. Böing, R. Metzger, P. M. Schneider, N. Tidow, B. Brandt, H. Buerger, E. Bulk, et al. 2003. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22 (39):8031–41. doi: 10.1038/sj.onc.1206928.
   PubMed Web of Science ®Google Scholar
• Ji, B. T., W. H. Chow, A. W. Hsing, J. K. McLaughlin, Q. Dai, Y. T. Gao, W. J. Blot, and J. F. Fraumeni Jr. 1997. Green tea consumption and the risk of pancreatic and colorectal cancers. International Journal of Cancer 70 (3):255–58. doi: 10.1002/(SICI)1097-0215(19970127)70:3<255::AID-IJC1>3.0.CO;2-W.
   PubMed Web of Science ®Google Scholar
• Jian, L., L. P. Xie, A. H. Lee, and C. W. Binns. 2004. Protective effect of green tea against prostate cancer: A case-control study in southeast China. International Journal of Cancer 108 (1):130–35. doi: 10.1002/ijc.11550.
   PubMed Web of Science ®Google Scholar
• Kado, K., A. Forsyth, P. R. Patel, and J. A. Schwartz. 2012. Dietary supplements and natural products in breast cancer trials. Frontiers in Bioscience E4 (1):546–67. doi: 10.2741/e399.
   Google Scholar
• Kanwal, R., M. Datt, X. Liu, and S. Gupta. 2016. Dietary flavones as dual inhibitors of DNA methyltransferases and histone methyltransferases. PLoS One 11 (9):e0162956. doi: 10.1371/journal.pone.0162956.
   PubMed Web of Science ®Google Scholar
• Kanwal, R., and S. Gupta. 2012. Epigenetic modifications in cancer. Clinical Genetics 81 (4):303–11. doi: 10.1111/j.1399-0004.2011.01809.x.
   PubMed Web of Science ®Google Scholar
• Kasala, E. R., L. N. Bodduluru, C. C. Barua, and R. Gogoi. 2016. Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis. Biomedicine & Pharmacotherapy 82:568–77. doi: 10.1016/j.biopha.2016.05.042.
   PubMed Web of Science ®Google Scholar
• Kashyap, D., A. Sharma, K. Sak, H. S. Tuli, H. S. Buttar, and A. Bishayee. 2018. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sciences 194:75–87. doi: 10.1016/j.lfs.2017.12.005.
   PubMed Web of Science ®Google Scholar
• Kauntz, H., S. Bousserouel, F. Gossé, and F. Raul. 2013. Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells. Oncology Letters 5 (4):1273–7. doi: 10.3892/ol.2013.1190.
   PubMed Web of Science ®Google Scholar
• Ketting, R. F., S. E. Fischer, E. Bernstein, T. Sijen, G. J. Hannon, and R. H. Plasterk. 2001. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes & Development 15 (20):2654–9. doi: 10.1101/gad.927801.
   PubMed Web of Science ®Google Scholar
• Khan, N., D. N. Syed, N. Ahmad, and H. Mukhtar. 2013. Fisetin: A dietary antioxidant for health promotion. Antioxidants & Redox Signaling 19 (2):151–62. doi: 10.1089/ars.2012.4901.
   PubMed Web of Science ®Google Scholar
• Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, Y. Tanaka, S. Majid, M. Igawa, and R. Dahiya. 2008. Genistein mediated histone acetylation and demethylation activate tumor suppressor genes in prostate cancer. International Journal of Cancer 123 (3):552–60. doi: 10.1002/ijc.23590.
   PubMed Web of Science ®Google Scholar
• Kim, H. J., J. H. Kim, E. K. Chie, P. Da Young, I. A. Kim, and I. H. Kim. 2012. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiation Oncology 7 (1):39. doi: 10.1186/1748-717X-7-39.
   PubMedGoogle Scholar
• Knight, S. W., and B. L. Bass. 2001. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 293 (5538):2269–71. doi: 10.1126/science.1062039.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128 (4):693–705. doi: 10.1016/j.cell.2007.02.005.
   PubMed Web of Science ®Google Scholar
• Kroonen, J., M. Artesi, V. Capraro, M.-T. Nguyen-Khac, M. Willems, A. Chakravarti, V. Bours, and P. A. Robe. 2012. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. International Journal of Oncology 41 (2):776–82. doi: 10.3892/ijo.2012.1489.
   PubMed Web of Science ®Google Scholar
• Kwon, Y. 2017. Luteolin as a potential preventive and therapeutic candidate for Alzheimer’s disease. Experimental Gerontology 95:39–43. doi: 10.1016/j.exger.2017.05.014.
   PubMed Web of Science ®Google Scholar
• Lan, F., and Y. Shi. 2009. Epigenetic regulation: Methylation of histone and non-histone proteins. Science in China Series C: Life Sciences 52 (4):311–22. doi: 10.1007/s11427-009-0054-z.
   PubMedGoogle Scholar
• Lau, N. C., L. P. Lim, E. G. Weinstein, and D. P. Bartel. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (5543):858–62. doi: 10.1126/science.1065062.
   PubMed Web of Science ®Google Scholar
• Lee, J. H., T. O. Khor, L. Shu, Z. Y. Su, F. Fuentes, and A. N. T. Kong. 2013. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacology & Therapeutics 137 (2):153–71. doi: 10.1016/j.pharmthera.2012.09.008.
   PubMed Web of Science ®Google Scholar
• Lee, J. Y., and G. Kong. 2016. Roles and epigenetic regulation of epithelial–mesenchymal transition and its transcription factors in cancer initiation and progression. Cellular and Molecular Life Sciences 73 (24):4643–60. doi: 10.1007/s00018-016-2313-z.
   PubMed Web of Science ®Google Scholar
• Lee, W. J., Y. R. Chen, and T. H. Tseng. 2011. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncology Reports 25:583–91. doi: 10.3892/or.2010.1097.
   PubMed Web of Science ®Google Scholar
• Lee, W. J., J. Y. Shim, and B. T. Zhu. 2005. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Molecular Pharmacology 68 (4):1018–30. doi: 10.1124/mol.104.008367.
   PubMed Web of Science ®Google Scholar
• Li, B., M. Carey, and J. L. Workman. 2007. The role of chromatin during transcription. Cell 128 (4):707–19. doi: 10.1016/j.cell.2007.01.015.
   PubMed Web of Science ®Google Scholar
• Li, Q., Y. Shao, X. Zhang, T. Zheng, M. Miao, L. Qin, B. Wang, G. Ye, B. Xiao, J. Guo, et al. 2015. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumor Biology 36 (3):2007–12. doi: 10.1007/s13277-014-2807-y.
   PubMed Web of Science ®Google Scholar
• Li, W., J. Zheng, J. Deng, Y. You, H. Wu, N. Li, J. Lu, and Y. Zhou. 2014. Increased levels of the long intergenic non–protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Gastroenterology 146 (7):1714–26. doi: 10.1053/j.gastro.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Li, W., M. Liu, Y. F. Xu, Y. Feng, J. P. Che, G. C. Wang, and J. H. Zheng. 2014. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a. Oncology Reports 31 (1):117–24. doi: 10.3892/or.2013.2811.
   PubMed Web of Science ®Google Scholar
• Li, X., Z. Wu, X. Fu, and W. Han. 2014. lncRNAs: Insights into their function and mechanics in underlying disorders. Mutation Research/Reviews in Mutation Research 762:1–21. doi: 10.1016/j.mrrev.2014.04.002.
   PubMed Web of Science ®Google Scholar
• Li, Y., L. Liu, L. G. Andrews, and T. O. Tollefsbol. 2009. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. International Journal of Cancer 125 (2):286–96. doi: 10.1002/ijc.24398.
   PubMed Web of Science ®Google Scholar
• Lin, C. W., G. M. Lai, K. C. Chen, T. H. Lin, J. J. Fan, R. L. Hsu, C. M. Chou, C. M. Lin, C. C. Kandaswami, M. T. Lee, et al. 2015. RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin. Journal of Functional Foods 19:236–47. doi: 10.1016/j.jff.2015.09.030.
   Web of Science ®Google Scholar
• Lin, F., X. Luo, A. Tsun, Z. Li, D. Li, and B. Li. 2015. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation. International Immunopharmacology 28 (2):859–65. doi: 10.1016/j.intimp.2015.03.044.
   PubMed Web of Science ®Google Scholar
• Link, A., F. Balaguer, and A. Goel. 2010. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochemical Pharmacology 80 (12):1771–92. doi: 10.1016/j.bcp.2010.06.036.
   PubMed Web of Science ®Google Scholar
• Liu, B., H. Yu, R. Baiyun, J. Lu, S. Li, Q. Bing, X. Zhang, and Z. Zhang. 2018. Protective effects of dietary luteolin against mercuric chloride-induced lung injury in mice: Involvement of AKT/Nrf2 and NF-κB pathways. Food and Chemical Toxicology 113:296–302. doi: 10.1016/j.fct.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Long, M. D., D. J. Smiraglia, and M. J. Campbell. 2017. The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer. Biomolecules 7 (4):15. doi: 10.3390/biom7010015.
   Google Scholar
• Lou, G., Y. Liu, S. Wu, J. Xue, F. Yang, H. Fu, M. Zheng, and Z. Chen. 2015. The p53/miR-34a/SIRT1 positive feedback loop in quercetin-induced apoptosis. Cellular Physiology and Biochemistry 35 (6):2192–202. doi: 10.1159/000374024.
   PubMed Web of Science ®Google Scholar
• Lu, L., Y. Wang, R. Ou, Q. Feng, L. Ji, H. Zheng, Y. Guo, X. Qi, A.-N T. Kong, Z. Liu, et al. 2018. DACT2 epigenetic stimulator exerts dual efficacy for colorectal cancer prevention and treatment. Pharmacological Research 129:318–28. doi: 10.1016/j.phrs.2017.11.032.
   PubMed Web of Science ®Google Scholar
• Lu, W., C. Lin, T. D. King, H. Chen, R. C. Reynolds, and Y. Li. 2012. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cellular Signalling 24 (12):2291–6. doi: 10.1016/j.cellsig.2012.07.009.
   PubMed Web of Science ®Google Scholar
• Lujambio, A., and S. W. Lowe. 2012. The microcosmos of cancer. Nature 482 (7385):347–55. doi: 10.1038/nature10888.
   PubMed Web of Science ®Google Scholar
• Lund, E., S. Güttinger, A. Calado, J. E. Dahlberg, and U. Kutay. 2004. Nuclear export of microRNA precursors. Science 303 (5654):95–8. doi: 10.1126/science.1090599.
   PubMed Web of Science ®Google Scholar
• MacRae, I. J., K. Zhou, and J. A. Doudna. 2007. Structural determinants of RNA recognition and cleavage by Dicer. Nature Structural & Molecular Biology 14 (10):934–40. doi: 10.1038/nsmb1293.
   PubMed Web of Science ®Google Scholar
• Mahmood, N., and S. A. Rabbani. 2019. DNA methylation readers and cancer: Mechanistic and therapeutic applications. Frontiers in Oncology 9:489. doi: 10.3389/fonc.2019.00489.
   PubMed Web of Science ®Google Scholar
• Majumdar, D., K.-H. Jung, H. Zhang, S. Nannapaneni, X. Wang, A. R. M. R. Amin, Z. Chen, Z. Chen, and D. M. Shin. 2014. Luteolin nanoparticle in chemoprevention: In vitro and in vivo anticancer activity. Cancer Prevention Research 7 (1):65–73. doi: 10.1158/1940-6207.CAPR-13-0230.
   PubMed Web of Science ®Google Scholar
• Mandery, K., K. Bujok, I. Schmidt, M. Keiser, W. Siegmund, B. Balk, J. König, M. F. Fromm, and H. Glaeser. 2010. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochemical Pharmacology 80 (11):1746–53. doi: 10.1016/j.bcp.2010.08.008.
   PubMed Web of Science ®Google Scholar
• Manzo-Merino, J., A. Contreras-Paredes, E. Vázquez-Ulloa, L. Rocha-Zavaleta, A. M. Fuentes-Gonzalez, and M. Lizano. 2014. The role of signaling pathways in cervical cancer and molecular therapeutic targets. Archives of Medical Research 45 (7):525–39. doi: 10.1016/j.arcmed.2014.10.008.
   PubMed Web of Science ®Google Scholar
• Martin, C., and Y. Zhang. 2005. The diverse functions of histone lysine methylation. Nature Reviews Molecular Cell Biology 6 (11):838–49. doi: 10.1038/nrm1761.
   PubMed Web of Science ®Google Scholar
• Martínez-Montemayor, M. M., E. Otero-Franqui, J. Martinez, A. De La Mota-Peynado, L. A. Cubano, and S. Dharmawardhane. 2010. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clinical & Experimental Metastasis 27 (7):465–80. doi: 10.1007/s10585-010-9336-x.
   PubMed Web of Science ®Google Scholar
• Mateen, S., K. Raina, C. Agarwal, D. Chan, and R. Agarwal. 2013. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. Journal of Pharmacology and Experimental Therapeutics 345 (2):206–14. doi: 10.1124/jpet.113.203471.
   PubMed Web of Science ®Google Scholar
• Mateen, S., K. Raina, A. K. Jain, C. Agarwal, D. Chan, and R. Agarwal. 2012. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics 7 (10):1161–72. doi: 10.4161/epi.22070.
   PubMed Web of Science ®Google Scholar
• McClure, J. J., X. Li, and C. J. Chou. 2018. Chapter six: Advances and challenges of HDAC inhibitors in cancer therapeutics. In Advances in cancer research, eds. K. D. Tew and P. B. Fisher, 183–211. Cambridge, MA: Academic Press.
   Google Scholar
• McGrath, J., and P. Trojer. 2015. Targeting histone lysine methylation in cancer. Pharmacology & Therapeutics 150:1–22. doi: 10.1016/j.pharmthera.2015.01.002.
   PubMed Web of Science ®Google Scholar
• Meeran, S. M., S. N. Patel, T. H. Chan, and T. O. Tollefsbol. 2011. A novel prodrug of epigallocatechin-3-gallate: Differential epigenetic hTERT repression in human breast cancer cells. Cancer Prevention Research 4 (8):1243–54. doi: 10.1158/1940-6207.CAPR-11-0009.
   PubMed Web of Science ®Google Scholar
• Michalak, E. M., and J. E. Visvader. 2016. Dysregulation of histone methyltransferases in breast cancer–Opportunities for new targeted therapies? Molecular Oncology 10 (10):1497–515. doi: 10.1016/j.molonc.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Milisav, I., B. Poljšak, and S. Ribarič. 2017. Reduced risk of apoptosis: Mechanisms of stress responses. Apoptosis 22 (2):265–83. doi: 10.1007/s10495-016-1317-3.
   PubMed Web of Science ®Google Scholar
• Miltonprabu, S., M. Tomczyk, K. Skalicka-Woźniak, L. Rastrelli, M. Daglia, S. F. Nabavi, S. M. Alavian, and S. M. Nabavi. 2017. Hepatoprotective effect of quercetin: From chemistry to medicine. Food and Chemical Toxicology 108:365–74. doi: 10.1016/j.fct.2016.08.034.
   PubMed Web of Science ®Google Scholar
• Mohammadi, V., S. Dehghani, B. Larijani, and L. Azadbakht. 2016. Ovarian cancer risk and nonisoflavone flavonoids intake: A systematic review of epidemiological studies. Journal of Research in Medical Sciences 21 (1):123. doi: 10.4103/1735-1995.196605.
   PubMedGoogle Scholar
• Morera, L., M. Lübbert, and M. Jung. 2016. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clinical Epigenetics 8 (1):57. doi: 10.1186/s13148-016-0223-4.
   PubMed Web of Science ®Google Scholar
• Moseley, V. R., J. Morris, R. W. Knackstedt, and M. J. Wargovich. 2013. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells. Anticancer Research 33:5325–33.
   PubMed Web of Science ®Google Scholar
• Nabavi, S. F., G. L. Russo, M. Daglia, and S. M. Nabavi. 2015. Role of quercetin as an alternative for obesity treatment: You are what you eat! Food Chemistry 179:305–10. doi: 10.1016/j.foodchem.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Nagle, D. G., D. Ferreira, and Y. D. Zhou. 2006. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 67 (17):1849–55. doi: 10.1016/j.phytochem.2006.06.020.
   PubMed Web of Science ®Google Scholar
• Neuhouser, M. L. 2004. Dietary flavonoids and cancer risk: Evidence from human population studies. Nutrition and Cancer 50 (1):1–7. doi: 10.1207/s15327914nc5001_1.
   PubMed Web of Science ®Google Scholar
• Ng, S., W. Yue, U. Oppermann, and R. Klose. 2009. Dynamic protein methylation in chromatin biology. Cellular and Molecular Life Sciences 66 (3):407–22. doi: 10.1007/s00018-008-8303-z.
   PubMed Web of Science ®Google Scholar
• Nguyen, A. V., M. Martinez, M. J. Stamos, M. P. Moyer, K. Planutis, C. Hope, and R. F. Holcombe. 2009. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Management and Research 1 (25). doi: 10.2147/CMAR.S4544.
   PubMedGoogle Scholar
• Nishikawaji, T., Y. Akiyama, S. Shimada, K. Kojima, T. Kawano, Y. Eishi, Y. Yuasa, and S. Tanaka. 2016. Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer. Oncotarget 7 (41):67251. doi: 10.18632/oncotarget.11625.
   PubMedGoogle Scholar
• Nothlings, U., S. Murphy, L. Wilkens, B. Henderson, and L. Kolonel. 2007. Flavonols and pancreatic cancer risk: The multiethnic cohort study. American Journal of Epidemiology 166 (8):924–31. doi: 10.1093/aje/kwm172.
   PubMed Web of Science ®Google Scholar
• Nwaeburu, C. C., A. Abukiwan, Z. Zhao, and I. Herr. 2017. Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Molecular Cancer 16 (1):23. doi: 10.1186/s12943-017-0589-8.
   PubMedGoogle Scholar
• Okamura, K., N. Liu, and E. C. Lai. 2009. Distinct mechanisms for microRNA strand selection by Drosophila Argonautes. Molecular Cell 36 (3):431–44. doi: 10.1016/j.molcel.2009.09.027.
   PubMed Web of Science ®Google Scholar
• Oloumi, A., T. McPhee, and S. Dedhar. 2004. Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochimica et Biophysica Acta (Bba) - Molecular Cell Research 1691 (1):1–15. doi: 10.1016/j.bbamcr.2003.12.002.
   PubMed Web of Science ®Google Scholar
• Orhan, I. E., S. F. Nabavi, M. Daglia, G. C. Tenore, K. Mansouri, and S. M. Nabavi. 2015. Naringenin and atherosclerosis: A review of literature. Current Pharmaceutical Biotechnology 16 (3):245–51. doi: 10.2174/1389201015666141202110216.
   PubMed Web of Science ®Google Scholar
• Palacz-Wrobel, M., P. Borkowska, M. Paul-Samojedny, M. Kowalczyk, A. Fila-Danilow, R. Suchanek-Raif, and J. Kowalski. 2017. Effect of apigenin, kaempferol and resveratrol on the gene expression and protein secretion of tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) in RAW-264.7 macrophages. Biomedicine & Pharmacotherapy 93:1205–12. doi: 10.1016/j.biopha.2017.07.054.
   PubMed Web of Science ®Google Scholar
• Pan, M. H., Y. S. Chiou, L. H. Chen, and C. T. Ho. 2015. Breast cancer chemoprevention by dietary natural phenolic compounds: Specific epigenetic related molecular targets. Molecular Nutrition & Food Research 59 (1):21–35. doi: 10.1002/mnfr.201400515.
   PubMed Web of Science ®Google Scholar
• Pandey, M., P. Kaur, S. Shukla, A. Abbas, P. Fu, and S. Gupta. 2012. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study. Molecular Carcinogenesis 51 (12):952–62. doi: 10.1002/mc.20866.
   PubMed Web of Science ®Google Scholar
• Pandey, M., S. Shukla, and S. Gupta. 2010. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re‐expression of GSTP1 in human prostate cancer cells. International Journal of Cancer 126:2520–33. doi: 10.1002/ijc.24988.
   PubMed Web of Science ®Google Scholar
• Pantuck, A. J., J. T. Leppert, N. Zomorodian, W. Aronson, J. Hong, R. J. Barnard, N. Seeram, H. Liker, H. Wang, R. Elashoff, et al. 2006. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clinical Cancer Research 12 (13):4018–26. doi: 10.1158/1078-0432.CCR-05-2290.
   PubMed Web of Science ®Google Scholar
• Park, H. H., S. Lee, J. M. Oh, M. S. Lee, K. H. Yoon, B. H. Park, J. W. Kim, H. Song, and S. H. Kim. 2007. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacological Research 55 (1):31–7. doi: 10.1016/j.phrs.2006.10.002.
   PubMed Web of Science ®Google Scholar
• Park, S. H., J. Kim, K. H. Do, J. Park, C. G. Oh, H. J. Choi, B. G. Song, S. J. Lee, Y. S. Kim, Y. Moon, et al. 2014. Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a non-canonical pathway under endoplasmic reticulum stress. Journal of Biological Chemistry 289 (39):27118–33. doi: 10.1074/jbc.M114.568717.
   PubMed Web of Science ®Google Scholar
• Patel, K. R., V. A. Brown, D. J. Jones, R. G. Britton, D. Hemingway, A. S. Miller, K. P. West, T. D. Booth, M. Perloff, et al. 2010. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Research 70 (19):7392–99. doi: 10.1158/0008-5472.CAN-10-2027.
   PubMed Web of Science ®Google Scholar
• Pauli, A., E. Valen, M. F. Lin, M. Garber, N. L. Vastenhouw, J. Z. Levin, L. Fan, A. Sandelin, J. L. Rinn, A. Regev, et al. 2012. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Research 22 (3):577–91. doi: 10.1101/gr.133009.111.
   PubMed Web of Science ®Google Scholar
• Petrick, J. L., S. E. Steck, P. T. Bradshaw, K. F. Trivers, P. E. Abrahamson, L. S. Engel, K. He, W. H. Chow, S. T. Mayne, H. A. Risch, et al. 2015. Dietary intake of flavonoids and oesophageal and gastric cancer: Incidence and survival in the United States of America (USA). British Journal of Cancer 112 (7):1291–300. doi: 10.1038/bjc.2015.25.
   PubMed Web of Science ®Google Scholar
• Peiffer, D. S. 2018. Preparing black raspberry components for their use as cancer therapeutics. Journal of Berry Research 8 (4):297–306. doi: 10.3233/JBR-180364.
   Web of Science ®Google Scholar
• Pfeifer, G. 2018. Defining driver DNA methylation changes in human cancer. International Journal of Molecular Sciences 19 (4):1166. doi: 10.3390/ijms19041166.
   PubMed Web of Science ®Google Scholar
• Pietrocola, F., G. Mariño, D. Lissa, E. Vacchelli, S. A. Malik, M. Niso-Santano, N. Zamzami, L. Galluzzi, M. C. Maiuri, G. Kroemer, et al. 2012. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle 11 (20):3851–60. [Mismatch] doi: 10.4161/cc.22027.
   PubMed Web of Science ®Google Scholar
• Portela, A., and M. Esteller. 2010. Epigenetic modifications and human disease. Nature Biotechnology 28 (10):1057–68. doi: 10.1038/nbt.1685.
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar, P., Y.-O. Son, S. P. Divya, L. Wang, L. Turcios, R. V. Roy, J. A. Hitron, D. Kim, J. Dai, P. Asha, et al. 2017. Quercetin inhibits Cr (VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget 8 (32):52118. doi: 10.18632/oncotarget.10130.
   PubMedGoogle Scholar
• Prior, R. L., and G. Cao. 2000. Antioxidant phytochemicals in fruits and vegetables: Diet and health implications. HortScience 35 (4):588–92. doi: 10.21273/HORTSCI.35.4.588.
   Web of Science ®Google Scholar
• Rajendran, P., E. Ho, D. E. Williams, and R. H. Dashwood. 2011. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clinical Epigenetics 3 (1):4. doi: 10.1186/1868-7083-3-4.
   PubMedGoogle Scholar
• Ratovitski, E. A. 2017. Anticancer natural compounds as epigenetic modulators of gene expression. Current Genomics 18 (2):175–205. doi: 10.2174/1389202917666160803165229.
   PubMed Web of Science ®Google Scholar
• Razin, A., and A. D. Riggs. 1980. DNA methylation and gene function. Science 210 (4470):604–10. doi: 10.1126/science.6254144.
   PubMed Web of Science ®Google Scholar
• Rietjens, I. M., A. M. Sotoca, J. Vervoort, and J. Louisse. 2013. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Molecular Nutrition & Food Research 57 (1):100–13. doi: 10.1002/mnfr.201200439.
   PubMed Web of Science ®Google Scholar
• Rimbach, G., C. Boesch-Saadatmandi, J. Frank, D. Fuchs, U. Wenzel, H. Daniel, W. L. Hall, and P. D. Weinberg. 2008. Dietary isoflavones in the prevention of cardiovascular disease–A molecular perspective. Food and Chemical Toxicology 46 (4):1308–19. doi: 10.1016/j.fct.2007.06.029.
   PubMed Web of Science ®Google Scholar
• Rinn, J. L., and H. Y. Chang. 2012. Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 81 (1):145–66. doi: 10.1146/annurev-biochem-051410-092902.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Paredes, M., and M. Esteller. 2011. Cancer epigenetics reaches mainstream oncology. Nature Medicine 17 (3):330–9. doi: 10.1038/nm.2305.
   PubMed Web of Science ®Google Scholar
• Romagnolo, D. F., and O. I. Selmin. 2012. Flavonoids and cancer prevention: A review of the evidence. Journal of Nutrition in Gerontology and Geriatrics 31 (3):206–38. doi: 10.1080/21551197.2012.702534.
   PubMedGoogle Scholar
• Sak, K., and H. Everaus. 2015. Epidemiological evidences on dietary flavonoids and breast cancer risk: A narrative review. Asian Pacific Journal of Cancer Prevention 16 (12):4843–7. doi: 10.7314/APJCP.2015.16.12.4843.
   PubMedGoogle Scholar
• Schneider-Stock, R., A. Ghantous, K. Bajbouj, M. Saikali, and N. Darwiche. 2012. Epigenetic mechanisms of plant-derived anticancer drugs. Frontiers in Bioscience 17 (1):129–73. doi: 10.2741/3919.
   Google Scholar
• Schnekenburger, M., M. Dicato, and M. Diederich. 2014. Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnology Advances 32 (6):1123–32. doi: 10.1016/j.biotechadv.2014.03.009.
   PubMed Web of Science ®Google Scholar
• Seelinger, G., I. Merfort, and C. M. Schempp. 2008. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Medica 74 (14):1667–77. doi: 10.1055/s-0028-1088314.
   PubMed Web of Science ®Google Scholar
• Seet, B. T., I. Dikic, M. M. Zhou, and T. Pawson. 2006. Reading protein modifications with interaction domains. Nature Reviews Molecular Cell Biology 7 (7):473–83. doi: 10.1038/nrm1960.
   PubMed Web of Science ®Google Scholar
• Shankar, E., R. Kanwal, M. Candamo, and S. Gupta. 2016. Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges. Proceedings of the Seminars in Cancer Biology 40-41:82–99. doi: 10.1016/j.semcancer.2016.04.002.
   PubMed Web of Science ®Google Scholar
• Sharma, A., D. Kashyap, K. Sak, H. S. Tuli, and A. K. Sharma. 2018. Therapeutic charm of quercetin and its derivatives: A review of research and patents. Pharmaceutical Patent Analyst 7 (1):15–32. doi: 10.4155/ppa-2017-0030.
   PubMed Web of Science ®Google Scholar
• Shi, L. B., P. F. Tang, W. Zhang, Y. P. Zhao, L. C. Zhang, and H. Zhang. 2016. Naringenin inhibits spinal cord injury-induced activation of neutrophils through miR-223. Gene 592 (1):128–33. doi: 10.1016/j.gene.2016.07.037.
   PubMed Web of Science ®Google Scholar
• Shiohama, A., T. Sasaki, S. Noda, S. Minoshima, and N. Shimizu. 2003. Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochemical and Biophysical Research Communications 304 (1):184–90. doi: 10.1016/S0006-291X(03)00554-0.
   PubMed Web of Science ®Google Scholar
• Shukla, S., and S. M. Meeran. 2014. Epigenetics of cancer stem cells: Pathways and therapeutics. Biochimica et Biophysica Acta (BBA) - General Subjects 1840 (12):3494–502. doi: 10.1016/j.bbagen.2014.09.017.
   PubMed Web of Science ®Google Scholar
• Si, Y., J. Liu, H. Shen, C. Zhang, Y. Wu, Y. Huang, Z. Gong, J. Xue, and T. Liu. 2019. Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell. Journal of Cellular and Molecular Medicine 23 (2):1095–105. doi: 10.1111/jcmm.14010.
   PubMed Web of Science ®Google Scholar
• Singh, B. N., S. Shankar, and R. K. Srivastava. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochemical Pharmacology 82 (12):1807–21. doi: 10.1016/j.bcp.2011.07.093.
   PubMed Web of Science ®Google Scholar
• Smith, C. J., and K. K. Ryckman. 2015. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 8:295.
   PubMed Web of Science ®Google Scholar
• Srinivasa, H., M. Bagul, H. Padh, and M. Rajani. 2004. A rapid densitometric method for the quantification of luteolin in medicinal plants using HPTLC. Chromatographia 60 (1–2):131–4. doi: 10.1365/s10337-004-0302-0.
   Web of Science ®Google Scholar
• Stresemann, C., B. Brueckner, T. Musch, H. Stopper, and F. Lyko. 2006. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Research 66 (5):2794–800. doi: 10.1158/0008-5472.CAN-05-2821.
   PubMed Web of Science ®Google Scholar
• Su, D., R. Zhang, F. Hou, J. Chi, F. Huang, S. Yan, L. Liu, Y. Deng, Z. Wei, and M. Zhang. 2017. Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet. Food & Function 8 (2):808–15. doi: 10.1039/C6FO01507G.
   PubMed Web of Science ®Google Scholar
• Subramaniam, D., R. Thombre, A. Dhar, and S. Anant. 2014. DNA methyltransferases: A novel target for prevention and therapy. Frontiers in Oncology 4:80. doi: 10.3389/fonc.2014.00080.
   PubMedGoogle Scholar
• Tabara, H., M. Sarkissian, W. G. Kelly, J. Fleenor, A. Grishok, L. Timmons, A. Fire, and C. C. Mello. 1999. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99 (2):123–32. doi: 10.1016/S0092-8674(00)81644-X.
   PubMed Web of Science ®Google Scholar
• Tang, N. P., B. Zhou, B. Wang, R. B. Yu, and J. Ma. 2009. Flavonoids intake and risk of lung cancer: A meta-analysis. Japanese Journal of Clinical Oncology 39 (6):352–59. doi: 10.1093/jjco/hyp028.
   PubMed Web of Science ®Google Scholar
• Tao, S. F., H. F. He, and Q. Chen. 2015. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells. Molecular and Cellular Biochemistry 402 (1–2):93–100. doi: 10.1007/s11010-014-2317-7.
   PubMed Web of Science ®Google Scholar
• Taverna, S. D., H. Li, A. J. Ruthenburg, C. D. Allis, and D. J. Patel. 2007. How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers. Nature Structural & Molecular Biology 14 (11):1025–40. doi: 10.1038/nsmb1338.
   PubMed Web of Science ®Google Scholar
• Thakur, V. S., G. Deb, M. A. Babcook, and S. Gupta. 2014. Plant phytochemicals as epigenetic modulators: Role in cancer chemoprevention. The AAPS Journal 16 (1):151–63. doi: 10.1208/s12248-013-9548-5.
   PubMed Web of Science ®Google Scholar
• Thomas, M., and P. Marcato. 2018. Epigenetic modifications as biomarkers of tumor development, therapy response, and recurrence across the cancer care continuum. Cancers 10 (4):101. doi: 10.3390/cancers10040101.
   Web of Science ®Google Scholar
• Tse, J. W. T., L. J. Jenkins, F. Chionh, and J. M. Mariadason. 2017. Aberrant DNA methylation in colorectal cancer: What should we target? Trends in Cancer 3 (10):698–712. doi: 10.1016/j.trecan.2017.08.003.
   PubMed Web of Science ®Google Scholar
• Tseng, T.-H., M.-H. Chien, W.-L. Lin, Y.-C. Wen, J.-M. Chow, C.-K. Chen, T.-C. Kuo, and W.-J. Lee. 2017. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression. Environmental Toxicology 32 (2):434–44. doi: 10.1002/tox.22247.
   PubMed Web of Science ®Google Scholar
• Ullah, H., and H. Khan. 2018. Anti-Parkinson potential of silymarin: Mechanistic insight and therapeutic standing. Frontiers in Pharmacology 9doi: 10.3389/fphar.2018.00422. [InsertedFromOnline
   Web of Science ®Google Scholar
• Vardi, A., R. Bosviel, N. Rabiau, M. Adjakly, S. Satih, P. Dechelotte, J.-P. Boiteux, L. Fontana, Y.-J. Bignon, L. Guy, et al. 2010. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo (Athens, Greece) 24 (4):393–400.
   PubMed Web of Science ®Google Scholar
• Varier, R. A., and H. M. Timmers. 2011. Histone lysine methylation and demethylation pathways in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815 (1):75–89. doi: 10.1016/j.bbcan.2010.10.002.
   PubMed Web of Science ®Google Scholar
• Vendrely, V., E. Peuchant, E. Buscail, I. Moranvillier, B. Rousseau, A. Bedel, A. Brillac, H. de Verneuil, F. Moreau-Gaudry, S. Dabernat, et al. 2017. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model. Cancer Letters 390:91–102. doi: 10.1016/j.canlet.2017.01.002.
   PubMed Web of Science ®Google Scholar
• Venturelli, S., T. W. Sinnberg, A. Berger, S. Noor, M. P. Levesque, A. BöCker, H. Niessner, U. M. Lauer, M. Bitzer, C. Garbe, et al. 2014. Epigenetic impacts of ascorbate on human metastatic melanoma cells. Frontiers in Oncology 4:227. doi: 10.3389/fonc.2014.00227.
   PubMedGoogle Scholar
• Waddington, C. H. 1942. The epigenotype. Endeavour 1:18–20.
   Google Scholar
• Wahlestedt, C. 2013. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nature Reviews Drug Discovery 12 (6):433–46. doi: 10.1038/nrd4018.
   PubMed Web of Science ®Google Scholar
• Wai Kan Yeung, A., B. B. Aggarwal, D. Barreca, M. Battino, T. Belwal, O. K. Horbańczuk, I. Berindan-Neagoe, A. Bishayee, M. Daglia, H. P. Devkota, et al. 2018. Dietary natural products and their potential to influence health and disease including animal model studies. Animal Science Papers & Reports 36 (4):345–58.
   Web of Science ®Google Scholar
• Wainwright, E. N., and P. Scaffidi. 2017. Epigenetics and cancer stem cells: Unleashing, hijacking, and restricting cellular plasticity. Trends in Cancer 3 (5):372–86. doi: 10.1016/j.trecan.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Wang, J., R. Ma, W. Ma, J. Chen, J. Yang, Y. Xi, and Q. Cui. 2016. LncDisease: A sequence based bioinformatics tool for predicting lncRNA-disease associations. Nucleic Acids Research 44 (9):e90. doi: 10.1093/nar/gkw093.
   PubMed Web of Science ®Google Scholar
• Wang, L.-S., C.-T. Kuo, S.-J. Cho, C. Seguin, J. Siddiqui, K. Stoner, Y.-I. Weng, T. H.-M. Huang, J. Tichelaar, M. Yearsley, et al. 2013. Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells. Nutrition and Cancer 65 (1):118–25. doi: 10.1080/01635581.2013.741759.
   PubMed Web of Science ®Google Scholar
• Wang, L.-S., M. Arnold, Y.-W. Huang, C. Sardo, C. Seguin, E. Martin, T. H.-M. Huang, K. Riedl, S. Schwartz, W. Frankel, et al. 2011. Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: A phase I pilot study. Clinical Cancer Research 17 (3):598–610. doi: 10.1158/1078-0432.CCR-10-1260.
   PubMed Web of Science ®Google Scholar
• Wang, P., T. Phan, D. Gordon, S. Chung, S. M. Henning, and J. V. Vadgama. 2015. Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Molecular Nutrition & Food Research 59 (2):250–61. doi: 10.1002/mnfr.201400558.
   PubMed Web of Science ®Google Scholar
• Wang, S., M. Cao, S. Xu, J. Zhang, Z. Wang, X. Mao, X. Yao, and C. Liu. 2017. Effect of luteolin on inflammatory responses in RAW264.7 macrophages activated with LPS and IFN-γ. Journal of Functional Foods 32:123–30. doi: 10.1016/j.jff.2017.02.018.
   Web of Science ®Google Scholar
• Wang, S., Y. Dong, Y. Zhang, X. Wang, L. Xu, S. Yang, X. Li, H. Dong, L. Xu, L. Su, et al. 2015. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer. Oncogene 34 (20):2575–85. doi: 10.1038/onc.2014.201.
   PubMed Web of Science ®Google Scholar
• Wang, Y., S. Juranek, H. Li, G. Sheng, T. Tuschl, and D. J. Patel. 2008. Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature 456 (7224):921–6. doi: 10.1038/nature07666.
   PubMed Web of Science ®Google Scholar
• Williams, R. J., J. P. Spencer, and C. Rice-Evans. 2004. Flavonoids: Antioxidants or signalling molecules? Free Radical Biology and Medicine 36 (7):838–49. doi: 10.1016/j.freeradbiomed.2004.01.001.
   PubMed Web of Science ®Google Scholar
• Wirbisky-Hershberger, S. E., O. F. Sanchez, K. A. Horzmann, D. Thanki, C. Yuan, and J. L. Freeman. 2017. Atrazine exposure decreases the activity of DNMTs, global DNA methylation levels, and dnmt expression. Food and Chemical Toxicology 109:727–34. doi: 10.1016/j.fct.2017.08.041.
   PubMed Web of Science ®Google Scholar
• Woo, H. D., and J. Kim. 2013. Dietary flavonoid intake and smoking-related cancer risk: A meta-analysis. PloS one 8 (9):e75604. doi: 10.1371/journal.pone.0075604.
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. 2007. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: American Institute for Cancer Research.
   Google Scholar
• Xavier, C. P. R., and C. Pereira-Wilson. 2016. Medicinal plants of the genuses Salvia and Hypericum are sources of anticolon cancer compounds: Effects on PI3K/Akt and MAP kinases pathways. PharmaNutrition 4 (2):112–22. doi: 10.1016/j.phanu.2015.11.002.
   Google Scholar
• Xhemalce, B., M. Dawson, and A. Bannister. 2011. Histone modifications. In Encyclopedia of molecular cell biology and molecular medicine, ed. R. Meyers. New York, NY: John Wiley and Sons.
   Google Scholar
• Xiang, T., Y. Fan, C. Li, L. Li, Y. Ying, J. Mu, W. Peng, Y. Feng, M. Oberst, K. Kelly, et al. 2016. Dact2 silencing by promoter cpg methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Oncotarget 7 (43):70924–35. doi: 10.18632/oncotarget.12341.
   PubMedGoogle Scholar
• Yan, N., L. Wen, R. Peng, H. Li, H. Liu, H. Peng, Y. Sun, T. Wu, L. Chen, Q. Duan, et al. 2016. Naringenin ameliorated kidney injury through let-7a/TGFBR1 signaling in diabetic nephropathy. Journal of Diabetes Research 2016:1–13. doi: 10.1155/2016/8738760.
   Web of Science ®Google Scholar
• Yang, X., L. Gao, X. Guo, X. Shi, H. Wu, F. Song, and B. Wang. 2014. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One 9 (1):e87797. doi: 10.1371/journal.pone.0087797.
   PubMed Web of Science ®Google Scholar
• Yarmishyn, A. A., and I. V. Kurochkin. 2015. Long noncoding RNAs: A potential novel class of cancer biomarkers. Frontiers in Genetics 6:145. doi: 10.3389/fgene.2015.00145.
   PubMed Web of Science ®Google Scholar
• Yi, R., Y. Qin, I. G. Macara, and B. R. Cullen. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development 17 (24):3011–6. doi: 10.1101/gad.1158803.
   PubMed Web of Science ®Google Scholar
• Yoo, C. B., and P. A. Jones. 2006. Epigenetic therapy of cancer: Past, present and future. Nature Reviews Drug Discovery 5 (1):37–50. doi: 10.1038/nrd1930.
   PubMed Web of Science ®Google Scholar
• Yoo, D. R., Y. H. Jang, Y. K. Jeon, J. Y. Kim, W. Jeon, Y. J. Choi, and M. J. Nam. 2009. Proteomic identification of anti-cancer proteins in luteolin-treated human hepatoma Huh-7 cells. Cancer Letters 282 (1):48–54. doi: 10.1016/j.canlet.2009.02.051.
   PubMed Web of Science ®Google Scholar
• You, J. S., and P. A. Jones. 2012. Cancer genetics and epigenetics: Two sides of the same coin? Cancer Cell 22 (1):9–20. doi: 10.1016/j.ccr.2012.06.008.
   PubMed Web of Science ®Google Scholar
• Youns, M., and W. A. H. Hegazy. 2017. The natural flavonoid fisetin inhibits cellular proliferation of hepatic, colorectal, and pancreatic cancer cells through modulation of multiple signaling pathways. PLoS One 12 (1):e0169335. doi: 10.1371/journal.pone.0169335.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros, R., D. K. Barupal, J. A. Rothwell, M. Jenab, V. Fedirko, I. Romieu, K. Aleksandrova, K. Overvad, C. Kyrø, A. Tjønneland, et al. 2017. Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. International Journal of Cancer 140 (8):1836–44. doi: 10.1002/ijc.30582.
   PubMed Web of Science ®Google Scholar
• Zhang, M., E. Linghu, Q. Zhan, T. He, B. Cao, M. V. Brock, J. G. Herman, R. Xiang, and M. Guo. 2016. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Development 7:17957–69.
   Google Scholar
• Zhang, S., B. Ling, F. Qu, and X. Sun. 2012. Investigation on the interaction between luteolin and calf thymus DNA by spectroscopic techniques. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 97:521–5. doi: 10.1016/j.saa.2012.06.040.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Q. Guo, J. Chen, and Z. Chen. 2015. Quercetin enhances cisplatin sensitivity of human osteosarcoma cells by modulating microRNA-217-KRAS axis. Molecules and Cells 38 (7):638–42. doi: 10.14348/molcells.2015.0037.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and H. Chen. 2011. Genistein, an epigenome modifier during cancer prevention. Epigenetics 6 (7):888–91. doi: 10.4161/epi.6.7.16315.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Q. Li, and H. Chen. 2013. DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development. Carcinogenesis 34 (8):1756–63. doi: 10.1093/carcin/bgt129.
   PubMed Web of Science ®Google Scholar
• Zhou, J., J. Gong, C. Ding, and G. Chen. 2015. Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145. Molecular Medicine Reports 12 (2):3127–31. doi: 10.3892/mmr.2015.3679.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., B. Z. Ding, Y. P. Lin, and H. B. Wang. 2018. MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1. Gene 644:56–65. doi: 10.1016/j.gene.2017.10.046.
   PubMed Web of Science ®Google Scholar
• Zwergel, C., S. Valente, and A. Mai. 2015. DNA methyltransferases inhibitors from natural sources. Current Topics in Medicinal Chemistry 16 (7):680–96. doi: 10.2174/1568026615666150825141505.
   Web of Science ®Google Scholar
• Zwicker, J. I., B. L. Schlechter, J. D. Stopa, H. A. Liebman, A. Aggarwal, M. Puligandla, T. Caughey, K. A. Bauer, N. Kuemmerle, E. Wong, et al. 2018. Targeting protein disulfide isomerase with the oral flavonoid isoquercetin 47 prevents venous thromboembolism in advanced cancer: Results of a multi-dose, multi-center, phase II clinical trial (CATIQ Study). American Society of Hematology 4 (4):125851.
   Google Scholar